News Room

Vaccine stocks Pfizer (PFE) and Moderna (MRNA) think they can get a handle on the coronavirus' delta variant. The two, along with other vaccine makers, have ambitious booster shot plans. But regardless of the outcome, experts say the Covid donnybrook is far from over.

More than nine months into the effort to vaccinate Americans against COVID-19, the patchwork nature of vaccination records is keeping Philadelphia hospitals from getting clarity on whether patients have had the shot.

Join host Michael Keegan next week for Special Edition of The Business of Government Hour – COVID-19 and its Impact: a series on how the pandemic has transform government management and operations with guest Dr. Rob Handfield–discussing key steps in building national supply chain immunity.

Julie Swann, an engineer who studies health systems and models infectious disease at North Carolina State University, leads a team of researchers who recently tried to simulate how the Delta variant of the coronavirus could move through schools in various scenarios. The results, which The Washington Post published over the weekend, were alarming.

If you happened to have access to infinite monkeys typing on infinite computers for an infinite amount of time, you might eventually end up with the perfect redistricting map.